Literature DB >> 8004807

Mucosal immunology research design should address not just cytokines and cells, but also clinical data and controls.

S Ghosh, A Ferguson.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8004807      PMCID： PMC1534566          DOI： 10.1111/j.1365-2249.1994.tb06037.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  13 in total

1.  Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease.

Authors:  C P Choudari; S O'Mahony; G Brydon; O Mwantembe; A Ferguson
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

2.  Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.

Authors:  S H Saverymuttu; A M Peters; J P Lavender; M B Pepys; H J Hodgson; V S Chadwick
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

Review 3.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease.

Authors:  G Malizia; A Calabrese; M Cottone; M Raimondo; L K Trejdosiewicz; C J Smart; L Oliva; L Pagliaro
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

5.  Structure and functional expression of a human interleukin-8 receptor.

Authors:  W E Holmes; J Lee; W J Kuang; G C Rice; W I Wood
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

6.  Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.

Authors:  Y Raab; B Gerdin; S Ahlstedt; R Hällgren
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

7.  Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells.

Authors:  K R Youngman; P L Simon; G A West; F Cominelli; D Rachmilewitz; J S Klein; C Fiocchi
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

8.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; E Schmidt; C Schümichen; P Billmann; H Schmidt; W Gerok
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

9.  Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.

Authors:  S H Saverymuttu; M Camilleri; H Rees; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

10.  IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease.

Authors:  K Mitsuyama; A Toyonaga; E Sasaki; K Watanabe; H Tateishi; T Nishiyama; T Saiki; H Ikeda; O Tsuruta; K Tanikawa
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330
View more
  2 in total

1.  Ulcerative colitis and Crohn's disease.

Authors:  A Ferguson
Journal:  BMJ       Date:  1994-08-06

2.  Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.

Authors:  M Noguchi; N Hiwatashi; Z Liu; T Toyota
Journal:  Gut       Date:  1998-08       Impact factor: 23.059
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.